BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 16550361)

  • 1. The pharmacokinetics and immunosuppressive response of tacrolimus in paediatric renal transplant recipients.
    Montini G; Ujka F; Varagnolo C; Ghio L; Ginevri F; Murer L; Thafam BS; Carasi C; Zacchello G; Plebani M
    Pediatr Nephrol; 2006 May; 21(5):719-24. PubMed ID: 16550361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of tacrolimus in adult renal transplant recipients.
    Naik P; Madhavarapu M; Mayur P; Nayak KS; Sritharan V
    Drug Metabol Drug Interact; 2012; 27(3):151-5. PubMed ID: 23089531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Pilot Study of the Pharmacokinetics of the Modified-Release Once-Daily Tacrolimus Formulation Administered to Living-Donor Liver Transplant Recipients.
    Song GW; Lee SG; Hwang S; Kim KH; Kim WJ; Sin MH; Yoon YI; Tak EY
    Exp Clin Transplant; 2016 Aug; 14(4):412-8. PubMed ID: 26976646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical efficacy and pharmacokinetics of tacrolimus in children with steroid-resistant nephrotic syndrome.
    Jahan A; Prabha R; Chaturvedi S; Mathew B; Fleming D; Agarwal I
    Pediatr Nephrol; 2015 Nov; 30(11):1961-7. PubMed ID: 26135137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of tacrolimus (FK 506) in children and adolescents with renal transplants.
    Filler G; Grygas R; Mai I; Stolpe HJ; Greiner C; Bauer S; Ehrich JH
    Nephrol Dial Transplant; 1997 Aug; 12(8):1668-71. PubMed ID: 9269646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-dependency of mycophenolate mofetil dosing in combination with tacrolimus after pediatric renal transplantation.
    Filler G; Foster J; Berard R; Mai I; Lepage N
    Transplant Proc; 2004 Jun; 36(5):1327-31. PubMed ID: 15251324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conversion of twice-daily tacrolimus to once-daily tacrolimus formulation in stable pediatric kidney transplant recipients: pharmacokinetics and efficacy.
    Min SI; Ha J; Kang HG; Ahn S; Park T; Park DD; Kim SM; Hong HJ; Min SK; Ha IS; Kim SJ
    Am J Transplant; 2013 Aug; 13(8):2191-7. PubMed ID: 23734831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical pharmacokinetics of tacrolimus in rescue therapy after renal transplantation.
    Budde K; Fritsche L; Mai I; Bauer S; Smettan S; Waiser J; Hofmann T; Hauser I; Reinke P; Neumayer HH
    Int J Clin Pharmacol Ther; 1996 Nov; 34(11):493-7. PubMed ID: 8937932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential pharmacokinetic interaction of tacrolimus and cyclosporine on everolimus.
    Kovarik JM; Curtis JJ; Hricik DE; Pescovitz MD; Scantlebury V; Vasquez A
    Transplant Proc; 2006 Dec; 38(10):3456-8. PubMed ID: 17175302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical pharmacokinetics of tacrolimus after the first oral administration in combination with mycophenolate mofetil and prednisone in Chinese renal transplant recipients.
    Chen YH; Zheng KL; Chen LZ; Dai YP; Fei JG; Qiu J; Li J
    Transplant Proc; 2005 Dec; 37(10):4246-50. PubMed ID: 16387090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of tacrolimus (FK506) in paediatric liver transplant recipients.
    Wallemacq PE; Furlan V; Möller A; Schäfer A; Stadler P; Firdaous I; Taburet AM; Reding R; Clement De Clety S; De Ville De Goyet J; Sokal E; Lykavieris L; Van Leeuw V; Bernard O; Otte JB; Undre NA
    Eur J Drug Metab Pharmacokinet; 1998; 23(3):367-70. PubMed ID: 9842978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction between everolimus and tacrolimus in renal transplant recipients: a pharmacokinetic controlled trial.
    Pascual J; del Castillo D; Cabello M; Pallardó L; Grinyó JM; Fernández AM; Brunet M
    Transplantation; 2010 Apr; 89(8):994-1000. PubMed ID: 20335831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic equivalence and pharmacokinetics of generic tacrolimus formulation in de novo kidney transplant patients.
    Min SI; Ha J; Kim YS; Ahn SH; Park T; Park DD; Kim SM; Min SK; Hong H; Ahn C; Kim SJ
    Nephrol Dial Transplant; 2013 Dec; 28(12):3110-9. PubMed ID: 24084327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal Pharmacokinetics of Everolimus When Combined With Low-level of Tacrolimus in Elderly Renal Transplant Recipients.
    David-Neto E; Agena F; Ramos F; Triboni AHK; Romano P; de Almeida Rezende Ebner P; Coelho V; Galante NZ; Lemos FBC
    Transplantation; 2017 Sep; 101(9):2133-2138. PubMed ID: 27798513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of tacrolimus granules in pediatric de novo liver, kidney, and heart transplantation: The OPTION study.
    Webb NJA; Baumann U; Camino M; Frauca E; Undre N;
    Pediatr Transplant; 2019 Feb; 23(1):e13328. PubMed ID: 30665258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maturation of dose-corrected tacrolimus predose trough levels in pediatric kidney allograft recipients.
    Naesens M; Salvatierra O; Li L; Kambham N; Concepcion W; Sarwal M
    Transplantation; 2008 Apr; 85(8):1139-45. PubMed ID: 18431234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary immunosuppression with tacrolimus and low-dose mycophenolate mofetil in renal transplant recipients.
    Yeung S; Tsang WK; Tong KL; Wong SH; Lee W; Tang HL; Chan HW; Chan AY
    Transplant Proc; 2004 Sep; 36(7):2084-6. PubMed ID: 15518754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved pharmacokinetic monitoring of tacrolimus exposure after pediatric renal transplantation.
    Lee MN; Butani L
    Pediatr Transplant; 2007 Jun; 11(4):388-93. PubMed ID: 17493218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of tacrolimus primary immunosuppression in kidney transplant recipients.
    Braun F; Schütz E; Peters B; Talaulicar R; Grupp C; Undre N; Schäfer A; Armstrong VW; Oellerich M; Ringe B
    Transplant Proc; 2001 May; 33(3):2127-8. PubMed ID: 11377473
    [No Abstract]   [Full Text] [Related]  

  • 20. One-year results of basiliximab induction and tacrolimus associated with sequential steroid and MMF treatment in pediatric kidney transplant recipient.
    Montini G; Murer L; Ghio L; Pietrobon B; Ginevri F; Ferraresso M; Cardillo M; Scalamogna M; Perfumo F; Edefonti A; Zanon GF; Zacchello G
    Transpl Int; 2005 Jan; 18(1):36-42. PubMed ID: 15612981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.